ClinicalTrials.gg
Drug

Treosulfan clinical trials

Also written Ovastat, Trecondi and Grafapex.

studies test it
40
open now
10
in phase 3
8
first study started
2001

How each study uses treosulfan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the treosulfan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Jan 2025 · GRAFAPEX · NDA 214759 (FDA, Drugs@FDA)
European Union
20 Jun 2019 · Trecondi · EMEA/H/C/004751 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Treosulfan
29
Dihydroxybusulfan
7
Tresulfon
7
Treosulphan
6
1,2,3, 4-Butanetetrol, 1,4-dimethanesulfonate, [R-(R*,S*)]-
4

Brand

Ovastat
12
Trecondi
2
Treograft®
1

Other names

Grafapex
2

In one entry with another drug

Given together, or one or the other

Fludarabine, OKT3, Treosulfan, Thiotepa
2

Studies by the year they started

40 studies that test it; most in 2009 (5)

Studies that test treosulfan, by start year
YearStudies
20011
20032
20043
20053
20073
20082
20095
20101
20133
20141
20151
20161
20201
20212
20222
20233
20242
20251
20263

Who runs them

Industry 8 · Other 32

medac GmbH (7) · Fred Hutchinson Cancer Center (7) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (4) · St. Anna Kinderkrebsforschung (3) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Ciceri Fabio (1) · University Hospital Muenster (1) · Novartis Pharmaceuticals (1)

Often tested with

Tested in the same studies.

Fludarabine (10) · Thiotepa (4) · Etoposide (3) · Busulfan (2) · Fludarabine phosphate (2) · Pioglitazone (2) · Antilymphocyte Serum (2) · Muromonab-CD3 (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test treosulfan.

Studies

Open first, then newest update. How each study uses treosulfan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 40

See all 40 studies that test treosulfan →

Given beside what is tested · 2 — treosulfan is usual care or a partner of the new treatment

Codes

What other systems call treosulfan · ClinicalTrials.gg INT002696

  • MeSH (NLM) C018404treosulfanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) CO61ER3EPITREOSULFANConfirmed FDA, NLM, Wikidata
  • RxNorm 38508Confirmed FDA, Wikidata
  • Wikidata Q7838652treosulfanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1257TreosulfanOne source FDA
  • DrugBank DB11678One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.